{"id":"W3209066466","doi":"10.1136/ijgc-2021-igcs.1","title":"O001/#331 Empower-cervical 1/GOG-3016/ENGOT-CX9: results of phase 3 trial of cemiplimab vs investigator’s choice chemotherapy in recurrent/metastatic cervical carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Vinorelbine; Cervical cancer; Population; Adenocarcinoma; Chemotherapy; Oncology; Cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009572123,0.0005511385,0.000869357,0.0003340601,0.0003173632,0.0008519535,0.0007286574,0.001126288,0.03387338],"category_scores_gemma":[0.0007690463,0.0002595811,0.0008462927,0.0002983886,0.0005271479,0.0005302439,0.0002870913,0.0026295,0.003915543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008885738,"about_ca_system_score_gemma":0.001320607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002520144,"about_ca_topic_score_gemma":0.01095229,"domain_scores_codex":[0.9997208,0.0001070758,0.00001001814,0.0000389584,0.00004153758,0.00008159435],"domain_scores_gemma":[0.999553,0.00009487251,0.00005339811,0.00003317475,0.00002545771,0.0002399852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.422922,0.02632556,0.004763056,0.001298338,0.001260247,0.0002401109,0.0001489519,0.002923195,0.02598787,0.001960745,0.1335462,0.3786238],"study_design_scores_gemma":[0.6694938,0.217172,0.02311682,0.000331659,0.001045691,0.0003835718,0.0001373688,0.002990927,0.009105999,0.00165711,0.07450063,0.00006445793],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8704193,0.009461114,0.0009734873,0.01267289,0.001409461,0.004254892,0.02893241,0.000815552,0.07106082],"genre_scores_gemma":[0.8931654,0.005681927,0.004722112,0.008601078,0.0007446143,0.00281875,0.027141,0.0003604007,0.05676469],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03387338,"threshold_uncertainty_score":0.1133177,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04412350336334246,"score_gpt":0.4121404875033292,"score_spread":0.3680169841399867,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}